Scientists test cancer drug's potential to free HIV patients from daily pills
NCT ID NCT07145164
Summary
This study is testing whether a drug called N-803 (Interleukin-15) can help people with HIV control the virus without needing to take daily HIV medication. The drug stimulates immune cells that fight infected cells, potentially changing how HIV hides in the body. Researchers will temporarily stop participants' regular HIV medication to see if the immune-boosting treatment helps keep the virus under control.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCSF
San Francisco, California, 94044, United States
Conditions
Explore the condition pages connected to this study.